The nation of Zimbabwe has turned down a major American healthcare agreement worth 367 million US dollars (£272m) spanning five years over Washington's demand for confidential biological samples.
This rejection came to light following a official document from December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "unbalanced".
An official representative has since explained that the US was demanding access to genetic material for scientific study and commercial gain but was not willing to guarantee the resulting advantages from future medical innovations.
"We must now begin the difficult and regrettable process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged further talks to secure a agreement acceptable to both sides so the nation's critical HIV programme can proceed.
Wider Background
Zimbabwe's decision comes after a similar case in Kenya, where a high court blocked a similar health funding agreement after concerns were filed about the security of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral agreements to enhance openness and responsibility.
According to reports, Sixteen nations in Africa have so far agreed to similar health pacts, representing more than $18.3bn of fresh investment.
Details of the Declined Agreement
The money for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered extraordinary benefits for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment through US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," his statement read.
"Put simply, our nation would provide the basic resources for scientific discovery without any certainty that the final treatments would be accessible to our people should a future pandemic emerge."
Sovereignty and International Frameworks
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining systems already set up via the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This system is intended to ensure that when a nation contributes its information, the benefits – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to create them."
The government's concerns over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We welcome ongoing discussions with our American counterparts on how subsequent collaboration might be arranged in a way that honours the sovereignty and interests of each country."
Medical Community Reaction
A leading public health body expressed it recognised the government's concerns, but recommended that talks must proceed considering much of the nation's Aids initiatives relied on external financing.
"Where specific concerns exist, including those involving information security or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group added.
The situation emphasises the complex debate between accepting crucial international aid and safeguarding local interests in an increasingly interconnected world.